E977-0682 Screening compound: N-[(furan-2-yl)methyl]-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]piperidine-3-carboxamide

E977-0682 Screening compound: N-[(furan-2-yl)methyl]-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]piperidine-3-carboxamide
E977-0682 Screening compound: N-[(furan-2-yl)methyl]-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E977-0682
N-[(furan-2-yl)methyl]-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E977-0682

Molecular Formula

C21H25N3O5S (C21 H25 N3 O5 S)

Compound Name

N-[(furan-2-yl)methyl]-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]piperidine-3-carboxamide

IUPAC name

N-[(furan-2-yl)methyl]-1-[(2-oxo-2345-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1S(c(cc1)cc(CCC2)c1NC2=O)(=O)=O)NCc1ccco1

InChI

InChI=1S/C21H25N3O5S/c25-20-7-1-4-15-12-18(8-9-19(15)23-20)30(27,28)24-10-2-5-16(14-24)21(26)22-13-17-6-3-11-29-17/h3,6,8-9,11-12,16H,1-2,4-5,7,10,13-14H2,(H,22,26)(H,23,25)/t16-/m0/s1

InChI Key

BPCSHHOSBDSZNY-INIZCTEOSA-N

MDL Number (MFCD)

MFCD14934781

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.51

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.490

Distribution Coefficient, logD

1.490

Water Solubility, LogSw

-2.43

Polar Surface Area

89.197

Acid Dissociation Constant (pKa)

11.28

Base Dissociation Constant (pKb)

-2.87

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.90

E977-0682 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

KRAS-Targeted Library (16000 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E977-0682 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E977-0682?
Check Price and Availability of E977-0682, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E977-0682 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E977-0682
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E977-0682
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E977-0682 available by request